Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Yue Da International Holdings Limited ( (HK:0629) ) has shared an update.
Yue Da International Holdings Limited announced a non-legally binding term sheet for a potential acquisition of a 52% equity interest in Chengdu Organoidmed Medical Laboratory Ltd. This move aligns with China’s 14th Five-Year Plan, emphasizing organoid technology as a major breakthrough for disease modeling and personalized cancer treatment. The acquisition is expected to diversify Yue Da’s business and enhance shareholder value, capitalizing on the growing demand for personalized cancer treatments in China.
More about Yue Da International Holdings Limited
Yue Da International Holdings Limited, incorporated in the Cayman Islands, is a diversified company actively seeking new business opportunities to enhance long-term growth and shareholder value. The company is expanding its focus into the organoid technology sector, which is significant for precision tumor medicine and personalized cancer treatment.
YTD Price Performance: -25.00%
Technical Sentiment Signal: Sell
Current Market Cap: €27.76M
For an in-depth examination of 0629 stock, go to TipRanks’ Stock Analysis page.